Pricing Log in Create free account

Elicio Therapeutics, Inc. (ELTX) vs Werewolf Therapeutics, Inc. (HOWL)

Elicio Therapeutics, Inc. and Werewolf Therapeutics, Inc. are both Biotechnology companies. Elicio Therapeutics, Inc. and Werewolf Therapeutics, Inc. are of similar size ($48.5M and $48.2M). Elicio Therapeutics, Inc. grew revenue faster over the last twelve months: 921.0% against −5.21%. Elicio Therapeutics, Inc. has the higher net margin (0.00% vs −141.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Elicio Therapeutics, Inc. leads on 8 and Werewolf Therapeutics, Inc. on 8.

Valuation

Metric ELTX HOWL Biotechnology median
P/E n/m n/m 8.50
P/S 1.04 1.95 9.71
P/B 3.78 2.92 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 0.59 1.94 9.21
Earnings yield (139.10%) (74.49%) (33.15%)
Free cash flow yield (125.90%) (62.73%) (25.50%)

Profitability

Metric ELTX HOWL Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (128.18%) 0.00%
Net margin 0.00% (141.94%) 0.00%
Free cash flow margin 0.00% (122.51%) 0.00%
Return on equity (774.56%) (119.86%) (56.36%)
Return on assets (124.36%) (59.31%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ELTX HOWL Biotechnology median
Revenue growth (TTM) 921.02% (5.21%) 6.02%
EPS growth (last fiscal year) 39.29% 18.40% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELTX HOWL Biotechnology median
Debt to equity 1.20 0.00 0.00
Current ratio 2.77 2.91 4.72
Net debt to EBITDA 0.25 0.97 0.96

Dividend

Metric ELTX HOWL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELTX HOWL Biotechnology median
Market cap 48.22m 48.46m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack